Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early treatment of Atrial Fibrillation for Stroke Prevention Trial
2010-021258-20Phase 4Completed
- Sponsor
- Kompetenznetz Vorhofflimmern
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amiodarone and propafenone in Atrial fibrillation (AFib), stroke, heart failure (HF) and 2 more (2 arms), sponsored by Kompetenznetz Vorhofflimmern. Primary endpoint: Primary composite cardiovascular outcome. Started May 2011; status: completed.
02
Drugs
amiodaronepropafenone
03
Conditions
Atrial fibrillation (AFib)strokeheart failure (HF)myocardial infarction (MI)confusion
Beyond the preview
Go deeper on 2010-021258-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021258-20.